References
- Fasshauer, M., Blüher, M. Adipokines in health and disease. Trends in Pharmacological Sciences [online]. 2015, 36(7), 461–470 [cit. 2021-5-25]. ISSN 01656147. Dostupné z: doi:10.1016/j.tips.2015.04.014
- Wong, Ch. K., Cheung P. F.-Y., Lam, Ch. W. K.. Leptin-mediated cytokine release and migration of eosinophils: Implications for immunopathophysiology of allergic inflammation. European Journal of Immunology [online]. 2007, 37(8), 2337–2348 [cit. 2021-7-8]. ISSN 00142980. Dostupné z: doi:10.1002/eji.200636866
- Nolan, E., O'meara, Y. M., Godson, C. Lipid mediators of inflammation in obesity-related glomerulopathy. Nephrology Dialysis Transplantation [online]. 2013, 28(suppl 4), iv22–iv29 [cit. 2021-5-25]. ISSN 0931-0509. Dostupné z: doi:10.1093/ndt/gft392
- Dedinská, I, Žilinská Z. Nefrológia pre študentov lekárskych fakúlt : vysokoškolské skriptá. 1. vydanie. Martin: Jesseniova lekárska fakulta Univerzity Komenského v Martine. 2018. ISBN9788089694334.
- Stanescu, H. C., Arcos-Burgos, M., Medlar, A., et al. Risk HLA-DQA1 and PLA 2 R1 Alleles in Idiopathic Membranous Nephropathy. New England Journal of Medicine [online]. 2011, 364(7), 616–626 [cit. 2021-7-29]. ISSN 0028-4793. Dostupné z: doi:10.1056/NEJMoa1009742
- Kang, Y. E., Kim, J. M., Joung, K. H., et al. The Roles of Adipokines, Proinflammatory Cytokines, and Adipose Tissue Macrophages in Obesity-Associated Insulin Resistance in Modest Obesity and Early Metabolic Dysfunction. PLOS ONE [online]. 2016, 11(4) [cit. 2021-5-25]. ISSN 1932-6203. Dostupné z: doi:10.1371/journal.pone.0154003
- Teichtahl, A.J., Wluka, A.E., Proietto, J., et al. Obesity and the female sex are risk factors for knee osteoarthritis that may be attributable to systemic or local leptin biosynthesis and its cellular effects. Medical Hypotheses [online]. 2005, 65(2), 312–315 [cit. 2021-7-9]. ISSN 03069877. Dostupné z: doi:10.1016/j.mehy.2005.02.026
- Sato, Y., Tsukaguchi, H., Higasa, K. et al. Positive renal familial history in IgA nephropathy is associated with worse renal outcomes: a single-center longitudinal study. BMC Nephrol 22, 230 (2021). https://doi.org/10.1186/s12882-021-02425-8
- Jameson J. L., Fauci, A. S., Kasper, D. L., et al. Harrison's Principles of Internal Medicine (20th edition, Vol 2.). New York: McGraw Hill Education, (August 13, 2018), 4048 pages. ISBN-13: 978-1259644030
- Leeaphorn, N., Kue-A-Pai P., Thamcharoen, N., et al. Prevalence of Cancer in Membranous Nephropathy: A Systematic Review and Meta-Analysis of Observational Studies. American Journal of Nephrology [online]. 2014, 40(1), 29–35 [cit. 2021-7-29]. ISSN 1421-9670. Dostupné z: doi:10.1159/000364782
- Song, H., Chan J., Rovin, B. H. Induction of chemokine expression by adiponectin in vitro is isoform dependent. Translational Research [online]. 2009, 154(1), 18–26 [cit. 2021-7-29]. ISSN 19315244. Dostupné z: doi:10.1016/j.trsl.2009.04.003
- Whitehead, J. P., Richards, A. A., Hickman, I. J., et al. Adiponectin a key adipokine in the metabolic syndrome. Diabetes, Obesity and Metabolism [online]. 2006, 8(3), 264–280 [cit. 2021-7-28]. ISSN 1462-8902. Dostupné z: doi:10.1111/j.1463-1326.2005.00510.x
- Shabaka, A., Ribera, T.A., Fernández-Juárez, G. Focal Segmental Glomerulosclerosis: State-of-the-Art and Clinical Perspective. Online. Nephron. 2020, roč. 144, č. 9, s. 413–427. ISSN 1660-8151. Dostupné z: https://doi.org/10.1159/000508099. [cit. 2024-05-19].
- Karageorgiou, V., Furukawa, T. A., Tsigkaropoulou, E., et al. Adipokines in anorexia nervosa: A systematic review and meta-analysis. Psychoneuroendocrinology [online]. 2020, 112 [cit. 2021-5-25]. ISSN 03064530. Dostupné z: doi:10.1016/j.psyneuen.2019.104485
- Cotillard, A., Poitou, Ch., Torcivia, A., et al. Adipocyte Size Threshold Matters: Link with Risk of Type 2 Diabetes and Improved Insulin Resistance After Gastric Bypass. The Journal of Clinical Endocrinology & Metabolism [online]. 2014, 99(8), E1466–E1470 [cit. 2021-5-28]. ISSN 0021-972X. Dostupné z: doi:10.1210/jc.2014-1074
- Matsuzawa, Y. Adipocytokines: Emerging therapeutic targets. Current Atherosclerosis Reports [online]. 2005, 7(1), 58–62 [cit. 2021-5-26]. ISSN 1523-3804. Dostupné z: doi:10.1007/s11883-005-0076-3
- Gavrila, A., Peng, C.-K., Chan, J. L., et al. Diurnal and Ultradian Dynamics of Serum Adiponectin in Healthy Men: Comparison with Leptin, Circulating Soluble Leptin Receptor, and Cortisol Patterns. The Journal of Clinical Endocrinology & Metabolism [online]. 2003, 88(6), 2838–2843 [cit. 2021-5-27]. ISSN 0021-972X. Dostupné z: doi:10.1210/jc.2002-021721
- Blüher, M. Importance of adipokines in glucose homeostasis. Diabetes Management [online]. 2013, 3(5), 389–400 [cit. 2021-6-2]. ISSN 1758-1907. Dostupné z: doi:10.2217/dmt.13.35
- Lehr, S., Hartwig, S., Sell, H. Adipokines: A treasure trove for discovering biomarkers for metabolic disorders. PROTEOMICS Clinical Applications [online]. 2012, 6(1–2), 91–101 [cit. 2021-6-2]. ISSN 18628346. Dostupné z: doi:10.1002/prca.201100052
- Klöting, N., Blüher, M. Adipocyte dysfunction, inflammation, and metabolic syndrome. Reviews in Endocrine and Metabolic Disorders [online]. 2014, 15(4), 277–287 [cit. 2021-5-28]. ISSN 1389-9155. Dostupné z: doi:10.1007/s11154-014-9301-0
- Silha, J.V., Krsek, M., Skrha, J.V., et al. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. European Journal of Endocrinology [online]. 2003, 149(4), 331–335 [cit. 2021-6-3]. ISSN 0804-4643. Dostupné z: doi:10.1530/eje.0.1490331
- Blüher, M., Michael, M.D., Peroni, O. D., et al. Adipose Tissue Selective Insulin Receptor Knockout Protects against Obesity and Obesity-Related Glucose Intolerance. Developmental Cell [online]. 2002, 3(1), 25–38 [cit. 2021-6-1]. ISSN 15345807. Dostupné z: doi:10.1016/S15345807(02)00199-5
- Bogan, J. S., Lodish, H. F. Two Compartments for Insulin-Stimulated Exocytosis in 3t3-L1 Adipocytes Defined by Endogenous Acrp30 and Glut4. Journal of Cell Biology [online]. 1999, 146(3), 609–620 [cit. 2021-5-31]. ISSN 0021-9525. Dostupné z: doi:10.1083/jcb.146.3.609
- Liu, M., Liu, F. Regulation of adiponectin multimerization, signaling and function. Best Practice & Research Clinical Endocrinology & Metabolism [online]. 2014, 28(1), 25–31 [cit. 2021-7-28]. ISSN 1521690X. Dostupné z: doi:10.1016/j.beem.2013.06.003
- Luo, Y., Liu M. Adiponectin: a versatile player of innate immunity. Journal of Molecular Cell Biology [online]. 2016, 8(2), 120–128 [cit. 2021-7-28]. ISSN 1674-2788. Dostupné z: doi:10.1093/jmcb/mjw012
- Strobel, A., Issad, T., Camoin, L., et al. A leptin missense mutation associated with hypogonadism and morbid obesity. Nature Genetics [online]. 1998, 18(3), 213–215 [cit. 2021-6-19]. ISSN 1061-4036. Dostupné z: doi:10.1038/ng0398-213
- Weyer, Ch., Funahashi, T., Tanaka, S., et al. Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance and Hyperinsulinemia. The Journal of Clinical Endocrinology & Metabolism [online]. 2001, 86(5), 1930–1935 [cit. 2021-7-29]. ISSN 0021-972X. Dostupné z: doi:10.1210/jcem.86.5.7463
- Saladin, R., De Vos, P., Guerre-Millot, M., et al. Transient increase in obese gene expression after food intake or insulin administration. Nature [online]. 1995, 377(6549), 527–528 [cit. 2021-5-27]. ISSN 0028-0836. Dostupné z: doi:10.1038/377527a0
- Chow, W.-S., Cheung, B. M.Y., Tso, A.W.K., et al. Hypoadiponectinemia as a Predictor for the Development of Hypertension. Hypertension [online]. 2007, 49(6), 1455–1461 [cit. 2021-7-29]. ISSN 0194-911X. Dostupné z: doi:10.1161/HYPERTENSIONAHA.107.086835
- Nakamura, Y. Implications of plasma concentrations of adiponectin in patients with coronary artery disease. Heart [online]. 2004, 90(5), 528–533 [cit. 2021-7-29]. ISSN 0007-0769. Dostupné z: doi:10.1136/hrt.2003.011114
- Pischon, T, C.J Girman, Hotamisligil, G.S., et al. Plasma adiponectin levels and risk of myocardial infarction in men. ACC Current Journal Review [online]. 2004, 13(6) [cit. 2021-6-9]. ISSN 10621458. Dostupné z: doi:10.1016/j.accreview.2004.06.063
- Gonzalez-Gay MA, Llorca J, Garcia-Unzueta MT, et al. High-grade inflammation, circulating adiponectin concentrations, and cardiovascular risk factors in severe rheumatoid arthritis. Clinical and Experimental Rheumatology. 2008 Jul-Aug;26(4):596–603. PMID: 18799090.
- Fasshauer, M., Blüher M., Stumvoll M. Adipokines in gestational diabetes. The Lancet Diabetes & Endocrinology [online]. 2014, 2(6), 488–499 [cit. 2021-6-14]. ISSN 22138587. Dostupné z: doi:10.1016/S2213-8587(13)70176-1
- Foo, J.-P., Mantzoros, Ch. S.. Leptin in congenital or HIV-associated lipodystrophy and metabolic syndrome: A need for more mechanistic studies and large, randomized, placebo-controlled trials. Metabolism [online]. 2012, 61(10), 1331–1336 [cit. 2021-6-14]. ISSN 00260495. Dostupné z: doi:10.1016/j.metabol.2012.04.013
- Machowska, A., Carrero, J.J., Lindholm B., et al. Therapeutics targeting persistent inflammation in chronic kidney disease. Translational Research [online]. 2016, 167(1), 204–213 [cit. 2021-7-29]. ISSN 19315244. Dostupné z: doi:10.1016/j.trsl.2015.06.012
- Taube, A., Schlich, R., Sell, H., et al. Inflammation and metabolic dysfunction: links to cardiovascular diseases. American Journal of Physiology-Heart and Circulatory Physiology [online]. 2012, 302(11), H2148–H2165 [cit. 2021-7-9]. ISSN 0363-6135. Dostupné z: doi:10.1152/ajpheart.00907.2011